Exforge: ARB/CCB combination for better hypertension control
Authors
Abstract
Exforge is a combination of the ARB valsartan and the CCB amlodipine to treat patients whose blood pressure is not controlled with either component. In our review, Steve Chaplin presents the clinical data relating to its efficacy and adverse effects, and Professor McInnes comments on its role in hypertension. Copyright © 2007 Wiley Interface Ltd
Digital Object Identifier (DOI)
10.1002/psb.168 About DOI
Login/Logout
Journal Menu
- Home
- News
- Current Issue
- Archive Issues
- Learning Central
- Ask Prescriber
- Prescriber Blog
- Forthcoming Events
- Supplements
- Wiley Job Network






